|
|
Volumn 47, Issue 1, 2009, Pages 33-35
|
|
Modulation of the efficacy of temozolomide and dacarbazine melanoma treatment by DNA-repair factors in vivo and in vitro
a
|
|
Author keywords
Melanoma; MGMT; Mismatch repair; Single nucleotide polymorphisms; Temozolomide dacarbazine resistance
|
|
Indexed keywords
DACARBAZINE;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
PROTEIN MLH1;
PROTEIN MSH2;
TEMOZOLOMIDE;
ALKYLATING AGENT;
DNA METHYLTRANSFERASE;
DRUG DERIVATIVE;
MESSENGER RNA;
MGMT PROTEIN, HUMAN;
MLH1 PROTEIN, HUMAN;
MSH2 PROTEIN, HUMAN;
NUCLEAR PROTEIN;
POLYDEOXYRIBONUCLEOTIDE SYNTHASE;
PRODRUG;
SIGNAL TRANSDUCING ADAPTOR PROTEIN;
TUMOR SUPPRESSOR PROTEIN;
CANCER CELL CULTURE;
CONFERENCE PAPER;
DNA REPAIR;
DRUG RESPONSE;
GENE EXPRESSION;
GENE SEQUENCE;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
MAJOR CLINICAL STUDY;
MELANOMA;
PHARMACOGENETICS;
SINGLE NUCLEOTIDE POLYMORPHISM;
ARTICLE;
CELL SURVIVAL;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG RESISTANCE;
ENZYMOLOGY;
GENE EXPRESSION REGULATION;
GENETICS;
LYMPHOCYTE;
METABOLISM;
METHYLATION;
PATHOLOGY;
PHYSIOLOGY;
PROMOTER REGION;
TUMOR CELL LINE;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CELL LINE, TUMOR;
CELL SURVIVAL;
CLINICAL TRIALS AS TOPIC;
DACARBAZINE;
DNA MODIFICATION METHYLASES;
DNA REPAIR ENZYMES;
DRUG RESISTANCE, NEOPLASM;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LYMPHOCYTES;
MELANOMA;
METHYLATION;
MUTS HOMOLOG 2 PROTEIN;
NUCLEAR PROTEINS;
PRODRUGS;
PROMOTER REGIONS, GENETIC;
RNA, MESSENGER;
TUMOR SUPPRESSOR PROTEINS;
|
|
EID: 65349135825
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CPP47033 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (4)
|
